Bone scan in initial staging of prostate cancer

Area of Science:

• Oncology
• Radiology
• Pathology

Background:

• Prostate cancer is a leading cause of cancer death in men.
• Bone metastases are a common complication of advanced prostate cancer.
• Accurate staging is crucial for effective treatment planning.

Purpose of the Study:

• To analyze the patterns and prevalence of bone metastases in newly diagnosed prostate cancer patients using bone scans.
• To identify specific imaging patterns indicative of metastatic disease.
• To determine the utility of bone scans in staging prostate cancer based on PSA levels and other clinical factors.

Main Methods:

• Retrospective analysis of bone scans from 64 newly diagnosed prostate cancer patients.
• Evaluation of metastatic lesion patterns, including topography and intensity of uptake.
• Correlation of bone scan findings with prostate-specific antigen (PSA) levels and clinical stage.

Main Results:

• Metastases were detected in 45% of patients (29 out of 64).
• A clearly metastatic pattern was observed in 75% of cases with metastases.
• No metastatic disease was found in patients with PSA levels below 10 ng/ml.
• Multiple intense areas of uptake (IAU) and focal lesions on sacroiliacs were highly specific for metastases.
• The distribution of metastases suggested systemic spread, mirroring bone marrow distribution.

Conclusions:

• Bone scans are valuable for detecting prostate cancer bone metastases, with specific patterns indicating spread.
• Systemic spread is the most likely mechanism for bone metastases in prostate cancer.
• Staging bone scans should be prioritized for patients with PSA levels >10 ng/ml, poor differentiation, or advanced clinical stage.